A potent tetravalent T-cell–engaging bispecific antibody against CD33 in acute myeloid leukemia
Abstract: Acute myeloid leukemia (AML), the most common acute leukemia in adults and the second most common cancer in children, is still a lethal disease in the majority of patients, but immunologic approaches have improved outcome. Bispecific antibodies (BsAbs) are novel immunotherapeutics that can...
Shranjeno v:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2018-06-01
|
| Serija: | Blood Advances |
| Online dostop: | http://www.sciencedirect.com/science/article/pii/S247395292030985X |
| Oznake: |
Brez oznak, prvi označite!
|